Neoadjuvant Considerations for a Patient with HER2+ Early Breast Cancer, November 11, 2015

Attached you will find an invitation to a program sponsored by Genentech. Lori Ranallo ARNP-BC, CBCN from the University of Kansas Hospital Cancer Center will be speaking about Neoadjuvant considerations for a patient with HER2+ early breast cancer. The program will be at 630 at Red Prime Steakhouse. RSVPs must be sent to maddocks,,,, or at using event code 52275.

Click Here for more information.

No comments have been posted yet.